NR-11c
NR-11c is a selective and potent p38α PROTAC degrader. NR-11c effectively degrades p38α in a variety of tumor cells. When administered intraperitoneally or intravenously to mice, NR-11c primarily acts in the liver. NR-11c can be used in cancer research. (Pink: p38α inhibitor 5 ; Black: linker (HY-159800) ; Blue: VHL E3 ligase ligand (HY-112078) ).
Product Specifications
UNSPSC
12352005
Target
P38 MAPK; PROTACs
Type
Reference compound
Related Pathways
MAPK/ERK Pathway; PROTAC
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nr-11c.html
Purity
99.75
Solubility
DMSO : ≥ 100 mg/mL
Smiles
Molecular Formula
C59H71BrF2N10O8S
Molecular Weight
1198.22
References & Citations
[1]Cubillos-Rojas M, et al. Synthesis and Biological Activity of a VHL-Based PROTAC Specific for p38α. Cancers (Basel) . 2023 Jan 18;15 (3) :611.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
P38α
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytochrome P450 Reductase (POR) (NM_000941) Human Over-expression Lysate
Recombinant Human TUBG1/TUBG protein (His tag)
Recombinant Human TUBG1/TUBG protein (His tag)
